[#item_full_content] The Food and Drug Administration (FDA) has issued guidance making clear that it does not intend to interfere with implementation of a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. FDA Commissioner Marty Makary wrote in a two-page memo on Wednesday that the agency 
Read More
New FDA Enforcement Memo Clears Way For Hemp CBD Product Coverage Under New Medicare Plan
ByPot Shop News
April 2, 2026